The sperm density of American males may be declining at a rate of 1.5 percent per year. Yet even amid an historic expansion of government’s role in health care, male infertility has merited little discussion in mainstream discourse. Federal and state governments are conspicuously absent in identifying the drivers of male infertility. Nor are they facilitating access to many of the most promising therapies.
Such restraint from an otherwise expanding regulatory state is intriguing—and it is particularly noteworthy given that male infertility is considered a “fundamental biomarker of overall male health” and a barometer for male outcomes in American society generally.
No comments:
Post a Comment